Author

Samantha A. Swenson

Fred and Pamela Buffett Cancer CenterORCID 0000-0002-5650-3841Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Arjun DhiriD· 3 shared Calvin K. LamiD· 3 shared R. Katherine HydeiD· 3 shared Sipra PandaiD· 3 shared Kasidy K. Dobish· 2 shared Kyle J. HewittiD· 2 shared Peng XiaoiD· 2 shared Shannon M. BuckleyiD· 2 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Arjun DhirORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Tissue Specific Requirement for the Inv(16) Oncogene CBFB::MYH11 in Acute Myeloid Leukemia

Sipra Panda, Yiqian Wang, Venkatasai Rahul Dogiparthi, Michelle E. Becker, Arjun Dhir, Calvin K. Lam, Cecilia Rivas, Lemlem Alemu, Lisa J Garrett, Peng Xiao, Samantha A. Swenson, Kyle J. Hewitt, R. Katherine Hyde

This study shows that CBFB::MYH11 is required for leukemia survival in spleen and peripheral blood but not in bone marrow, where it can be bypassed.

Oncogene · Aug 17, 2026Peer-reviewedCancer Biology

Proteome landscape of B-cell malignancies identifies mantle cell lymphoma protein signature

Samantha A. Swenson, Carrie Winship, Kasidy K. Dobish, Karli J. Wittorf, Henry C.-H. Law, Julie Marie Vose, Timothy C. Greiner, Michael R. Green, Nicholas T. Woods, Shannon M. Buckley

The paper identifies a proteomic signature of mantle cell lymphoma (MCL) using quantitative proteomics, revealing 10 upregulated proteins that may serve as therapeutic targets.

bioRxiv · Apr 27, 2026 · PreprintCancer Biology

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4

Calvin K. Lam, Arjun Dhir, Arnob Mitro, Chinmay M. Jogdeo, Sipra Panda, Ekta Kapoor, Siyuan Tang, Victor J. Rivero, Erin M. McIntyre, Donald W. Coulter, Peng Xiao, Adrian R. Black, Kyle J. Hewitt, Svetlana Romanova, Samantha A. Swenson, , R. Katherine Hyde

This paper shows PAMD-Ch17, a modified Plerixafor analog, kills T-ALL cells via mitochondrial dysfunction independent of CXCR4 inhibition.

Molecular Cancer Therapeutics · Mar 26, 2026Peer-reviewedCancer Biology

The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival

Arjun Dhir, Alexander Ethell, Riley Watkins, Calvin K. Lam, Kevin Tur-Rodriguez, Jimmie Persinger, Kasidy K. Dobish, Sipra Panda, Shannon M. Buckley, Samantha A. Swenson, Sandipan Brahma, M. Jordan Rowley, R. Katherine Hyde

The paper identifies PTBP1 as a RUNX1 interacting partner required for leukemia cell survival through metabolic gene regulation.

Leukemia · Nov 10, 2025Peer-reviewedCancer Biology